2010•Chinese Journal of New Clinical MedicineRequires access

Observation on therapeutic effect of Shengmai injection in the adjuvant treatment of patients with acute exacerbation of chronic pulmonary heart disease

Chen Zhi-jua

Open publisher page 1 citations

Abstract

Objective To observe the clinical therapeutic effect of Shengmai injection in the adjuvant treatment of patients with acute exacerbation of chronic pulmonary heart disease.Methods One hundred patients with acute exacerbation of chronic pulmonary heart disease were randomly divided into the Shengmai group (50 patients) and the control group (50 patients).The patients in two groups were treated with conventional western medicine treatment.On the basis of above treatment, the patients in the Shengmai group were given intravenous drip of Shengmai injection 60 ml added into 5% glucose injection,once daily.The treatment course was 14 days.Results Increasing of PaO_2 level and decreasing of PcO_2 level in the Shengmai group were more remarkable than those in the control group ( all P 0.01). Total effective rate in the Shengmai group ( 92% ) was higher than that in the control group (68%)( P 0.01).Except xerostomia which occured in 2 patients,there was no obvious adverse reaction in the Shengmai group.Conclusion Shengmai injection in the adjuvant treatment of patients with acute exacerbation of chronic pulmonary heart disease has obvious therapeutic effect and less adverse reaction.It is worthy of further application.

About this research paper

What this paper is about

Objective To observe the clinical therapeutic effect of Shengmai injection in the adjuvant treatment of patients with acute exacerbation of chronic pulmonary heart disease.Methods One hundred patients with acute exacerbation of chronic pulmonary heart disease were randomly divided into the Shengmai group (50 patients) and the control group (50 patients).The patients in two groups were treated with conventional western medicine treatment.On the basis of above treatment, the patients in the Shengmai group were given intravenous drip of Shengmai injection 60 ml added into 5% glucose injection,once daily.The treatment course was 14 days.Results Increasing of PaO_2 level and decreasing of PcO_2 level in the Shengmai group were more remarkable than those in the control group ( all P 0.01). Total effective rate in the Shengmai group ( 92% ) was higher than that in the control group (68%)( P 0.01).Except xerostomia which occured in 2 patients,there was no obvious adverse reaction in the Shengmai group.Conclusion Shengmai injection in the adjuvant treatment of patients with acute exacerbation of chronic pulmonary heart disease has obvious therapeutic effect and less adverse reaction.It is worthy of further application.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical therapeutic effect of Shengmai injection in the adjuvant treatment of patients with acute exacerbation of chronic pulmonary heart disease.Methods One hundred patients with acute exacerbation of chronic pulmonary heart disease were randomly divided into the Shengmai group (50 patients) and the control group (50 patients).The patients in two groups were treated with conventional western medicine treatment.On the basis of above treatment, the patients in the Shengmai group were given intravenous drip of Shengmai injection 60 ml added into 5% glucose injection,once daily.The treatment course was 14 days.Results Increasing of PaO_2 level and decreasing of PcO_2 level in the Shengmai group were more remarkable than those in the control group ( all P 0.01). Total effective rate in the Shengmai group ( 92% ) was higher than that in the control group (68%)( P 0.01).Except xerostomia which occured in 2 patients,there was no obvious adverse reaction in the Shengmai group.Conclusion Shengmai injection in the adjuvant treatment of patients with acute exacerbation of chronic pulmonary heart disease has obvious therapeutic effect and less adverse reaction.It is worthy of further application.

Key concepts: Medicine, Exacerbation, Adjuvant, Therapeutic effect, Adverse effect, Pulmonary heart disease, Anesthesia, Adjuvant therapy

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation on therapeutic effect of Shengmai injection in the adjuvant treatment of patients with acute exacerbation of chronic pulmonary heart disease — Research Paper | ScholarLens